Effects of the IMP-dehydrogenase inhibitor, Tiazofurin, in bcr-abl positive acute myelogenous leukemia. Part II. In vitro studies.

Abstract

Inosine-5'-monophosphate-dehydrogenase (IMPDH) regulates the de novo synthesis of guanine ribonucleotides (GNT). IMPDH activity varies inversely with intracellular [GNT] and is linked to cellular proliferation. K562 leukemia cell growth was studied relative to IMPDH expression and activity following culture of the cells with Tiazofurin, an IMPDH inhibitor. Tiazofurin depressed IMPDH activity and [GTP] in K562 cells, and also increased IMPDH mRNA expression. Following exposure to Tiazofurin, K562 cell proliferation, entry into cycle, and sensitivity to cycle-active cytotoxic agents were increased. These findings indicate that the efficacy of standard chemotherapy in bcr-abl positive leukemias might be enhanced if combined sequentially with Tiazofurin.

• Authors: Daniel G Wright, Michael Boosalis, Karim Malek, Kristin Waraska
• Journal: Leukemia research (Leuk Res) Vol. 28 Issue 11 Pg. 1137-43 (Nov 2004) ISSN: 0145-2126 [Print] England
• PMID: 15380336 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)

Chemical References

• Antineoplastic Agents
• Enzyme Inhibitors
• RNA, Messenger
• Ribavirin
• IMP Dehydrogenase
• tiazofurin

Topics

• Antineoplastic Agents (pharmacology)
• Enzyme Inhibitors (pharmacology)
• Gene Expression Regulation, Enzymologic (drug effects)
• Gene Expression Regulation, Neoplastic (drug effects)
• Humans
• IMP Dehydrogenase (antagonists & inhibitors, genetics, metabolism)
• In Vitro Techniques
• K562 Cells
• RNA, Messenger (genetics)
• Ribavirin (analogs & derivatives, pharmacology)